MediFind
Condition

Spastic Paraplegia Type 4

Symptoms, Doctors, Treatments, Research & More

Condition 101

What is the definition of Spastic Paraplegia Type 4?

Spastic paraplegia type 4 (also known as SPG4) is the most common of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterized by progressive muscle stiffness (spasticity) in the legs and difficulty walking. Hereditary spastic paraplegias are divided into two types: pure and complex. The pure types generally involve only spasticity of the lower limbs and walking difficulties. The complex types involve more widespread problems with the nervous system; the structure or functioning of the brain; and the nerves connecting the brain and spinal cord to muscles and sensory cells that detect sensations such as touch, pain, heat, and sound (the peripheral nervous system). In complex forms, there can also be features outside of the nervous system. Spastic paraplegia type 4 is usually a pure hereditary spastic paraplegia, although a few complex cases have been reported.

Like all hereditary spastic paraplegias, spastic paraplegia type 4 involves spasticity of the leg muscles and muscle weakness. People with this condition can also experience exaggerated reflexes (hyperreflexia), ankle spasms, high-arched feet (pes cavus), and reduced bladder control. Spastic paraplegia type 4 generally affects nerve and muscle function in the lower half of the body only.

What are the causes for Spastic Paraplegia Type 4?

Mutations in the SPAST gene cause spastic paraplegia type 4. The SPAST gene provides instructions for producing a protein called spastin. Spastin is found throughout the body, particularly in certain nerve cells (neurons). The spastin protein plays a role in the function of microtubules, which are rigid, hollow fibers that make up the cell's structural framework (the cytoskeleton). Microtubules are also involved in transporting cell components and facilitating cell division. Spastin likely helps restrict microtubule length and disassemble microtubule structures when they are no longer needed. Mutations in spastin impair the microtubules' ability to transport cell compartments (organelles), especially in nerve cells; researchers believe this contributes to the major signs and symptoms of spastic paraplegia type 4.

How prevalent is Spastic Paraplegia Type 4?

The prevalence of spastic paraplegia type 4 is estimated to be 2 to 6 in 100,000 people worldwide.

Is Spastic Paraplegia Type 4 an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In most cases, an affected person inherits the mutation from one affected parent. The remaining cases may result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.

Top Global Doctors

GR
Elite
Guy A. Rouleau
Montreal, QC, CA
CB
Elite
Christian Beetz
Rostock, MV, DE
LS
Elite
Ludger Schols
Tuebingen, BW, DE
RS
Elite
Rebecca Schule
Tuebingen, BW, DE
GS
Elite
Giovanni Stevanin
Paris, 11, FR
CD
Elite
Christel Depienne
Paris, 11, FR

Latest Research

Latest Advance
Study
  • Condition: Hereditary Spastic Paraplegia Type 4 (SPG4)
  • Journal: Journal of neurology
  • Treatment Used: Regular Screening for Non-Motor Symptoms
  • Number of Patients: 118
  • Published —
This study evaluated the effectiveness of regular screening for non-motor symptoms in patients with hereditary spastic paraplegia type 4 (spasticity of the leg muscles and muscle weakness; SPG4).

Clinical Trials

Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 200
  • Start Date: July 1, 2018
Studying the Presymptomatic and Early Phase of SPG4